Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|20|2964-2973

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.20, 2012-07, pp. : 2964-2973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Prospects for Kinase Activity Modulators in the Treatment of Diabetes and Diabetic Complications

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 915-938

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

By Miyamoto Shuichi  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 621-631

Informa Healthcare

Access to resources Recommend Favorite

Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice

By Buyukafsar K.   Un I.  

European Journal of Pharmacology, Vol. 472, Iss. 3, 2003-07 ,pp. : 235-238

Elsevier

Access to resources Recommend Favorite

Rho-kinase inhibitors show promise in pulmonary hypertension

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1157-1159

Informa Healthcare

Access to resources Recommend Favorite